Company expands worldwide footprint to China, Hong Kong, India, Singapore, South Korea and Taiwan for sales, distribution, and support of enzymatic synthesis products SOUTH SAN FRANCISCO, Calif., and PARIS — DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has reached agreements with several leading biotechnology distribution companies throughout the Asia-Pacific […]

MUNICH — NanoTemper Technologies, in partnership with PharmAI, announced the launch of Proto, a free AI-based web application that reveals the best labeling strategy to help scientists more efficiently measure molecular interactions, a process that’s necessary to discover and develop new drugs. Proto is one of the first commercial applications using the AlphaFold protein structure database that was […]

One of World’s Largest DNA Supply Agreements Enables Diverse Product Development Across Multiple Industries SOUTH SAN FRANCISCO, Calif. & BOSTON — Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, today announced a new […]

PODS-PeptiGels combine two stand-out technologies in single customisable cell culture environment Provides researchers with a predictable and controlled system, with potential for long-term experiments and reduced hands-on time Cambridge and Manchester, UK: Cell Guidance Systems Ltd, a specialist in the control, manipulation, and monitoring of cells, both in vitro and in vivo, and Manchester BIOGEL, a biotechnology company […]

Lonza has expanded the Cocoon® Platform functionality by releasing the second-generation instrument, including new integrated capabilities in cell binding, cell separation, and bead removal The Magnetic Selection capability, which can be utilized at any point in the cell therapy manufacturing process, provides a high level of customization and consistency and expands the end-to-end solution for cell […]

New Trading Symbol (NASDAQ:LAB) Expected to be Effective April 6, 2022  Appoints New Management Team and Additional Board Members with Significant Experience to Reinvigorate Growth and Enhance Product Portfolio  Embarks on New Chapter of Focused Execution and Growth  SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM) today announced the closing of the previously announced strategic […]

Tolochenaz, Vaud, Switzerland — Nanolive SA, a leading live cell imaging and analysis company, announces today that it has successfully completed the initial closing of US $20 million in the Series C-1 equity financing round of investment, led by a US-based and NASDAQ listed life science investor, and Taiwania Capital, the leading life science venture capital […]

ATCC’s collection of high-fidelity, authenticated DNA-seq and RNA-seq datasets to be included in QIAGEN’s databases for biotechnology and pharmaceutical companies for research Manassas, VA, United States ATCC, the world’s premier biological materials management and standards organization, today announced that it has entered into an agreement with QIAGEN, a recognized leader in bioinformatics solutions, to provide them […]

Scientific Solutions business splits from global medtech company TOKYO, Japan—Olympus Corporation (“Olympus”) announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation (“Evident”). Following the divestiture of its Imaging business, this move further signifies the company’s long-term strategy to cement its position as a major player in the […]